EICHOR
● Completed
Cough Reduction in IPF With Nalbuphine ER
Condition: Idiopathic Pulmonary Fibrosis · Sponsor: Trevi Therapeutics
About this study
The main purpose of the study is to evaluate the effect of NAL ER on 24-hour cough frequency using objective digital cough monitoring and to assess safety and tolerability of NAL ER.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (59)
| Eastern Health-Box Hill Hospital | Box Hill, Australia | — |
| Concord Repatriation General Hospital | Concord, Australia | — |
| Austin Hospital | Heidelberg, Australia | — |
| Respiratory Clinical Trials Pty Ltd | Kent Town, Australia | — |
| TrialsWest Pty Ltd | Spearwood, Australia | — |
| Westmead Hospital | Westmead, Australia | — |
| CIC Mauricie Inc. | Trois-Rivières, Quebec, Canada | — |
| Dynamic Drug Advancement | Ajax, Canada | — |
| Centre for Lung Health Clinic | Vancouver, Canada | — |
| The Pacific Lung Health Centre - St. Pauls Hospital | Vancouver, Canada | — |
| Hospital Clinico Regional Dr. Guillermo Grant Benavente | Concepción, Chile | — |
| Centro Respiratorio Integral Ltda | Quillota, Chile | — |
+ 47 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05964335